Answers are grounded in this paper and cite their sources.
A 15-year-old adolescent boy developed severe, treatment-refractory upper limb complex regional pain syndrome (CRPS) after a COVID-19 vaccination, characterized by initial hand paresthesia that progressed to widespread severe pain, allodynia, marked range-of-motion limitations, trophic changes, and insomnia.Although nerve conduction studies (NCS) were reported as normal, severe allodynia prevented distal evaluation.We devised a stepwise diagnostic block, which isolated the primary pain generator to the carpal tunnel.A meticulous re-evaluation of the NCS data also revealed findings consistent with minimal carpal tunnel syndrome (Padua class 2).Surgical intervention, including median nerve neurolysis, tenosynovectomy, and release of the ulnar artery, based on these findings, resulted in remarkable and sustained improvement in pain, insomnia, and upper limb function over a two-year follow-up.This case highlights that underlying peripheral pathology, identifiable by innovative diagnostic blocks and careful NCS re-evaluation, can be a treatable primary driver of severe post-vaccination CRPS.
No takes yet. Share an insight, caveat, or question.
Hagiwara et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: